Phase 1b trial of Isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma
Phase 1b trial of Isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma
Author List
Martin T, Shah N, Richter J, Vesole D, Wong SW, Huang CY, Madduri D, Jagannath S, Seigel D, Biran N, Wolf J, Parekh S, Cho HJ, Munster P, Richard S, Campana F, and Chari A
